UMB Bank n.a. lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 4.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 10,208 shares of the medical equipment provider's stock after purchasing an additional 466 shares during the period. UMB Bank n.a.'s holdings in Intuitive Surgical were worth $2,049,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in ISRG. Mitchell Mcleod Pugh & Williams Inc. lifted its stake in shares of Intuitive Surgical by 7.9% during the first quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 679 shares of the medical equipment provider's stock valued at $205,000 after acquiring an additional 50 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Intuitive Surgical by 0.9% during the first quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider's stock valued at $133,012,000 after acquiring an additional 3,982 shares during the period. MCIA Inc lifted its stake in shares of Intuitive Surgical by 5.6% during the first quarter. MCIA Inc now owns 3,596 shares of the medical equipment provider's stock valued at $1,003,000 after acquiring an additional 190 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Intuitive Surgical by 2.6% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 37,616 shares of the medical equipment provider's stock valued at $7,550,000 after acquiring an additional 952 shares during the period. Finally, Raymond James Financial Services Advisors Inc. lifted its stake in shares of Intuitive Surgical by 0.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 88,814 shares of the medical equipment provider's stock valued at $26,793,000 after acquiring an additional 578 shares during the period. Institutional investors own 82.44% of the company's stock.
Get
Intuitive Surgical alerts:
Intuitive Surgical Stock Performance
NASDAQ:ISRG opened at $187.44 on Friday. The company has a market cap of $66.94 billion, a PE ratio of 47.69, a PEG ratio of 5.26 and a beta of 1.31. Intuitive Surgical, Inc. has a 52-week low of $184.94 and a 52-week high of $369.69. The stock has a 50-day simple moving average of $216.24 and a 200 day simple moving average of $229.94.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). The firm had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.56 billion. Intuitive Surgical had a return on equity of 12.04% and a net
margin of 24.05%. During the same quarter in the previous year, the business posted $1.42 earnings per share. On average, research analysts predict that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on ISRG. Truist Financial cut their price target on Intuitive Surgical from $270.00 to $255.00 and set a "buy" rating on the stock in a research note on Friday, July 22nd. Raymond James cut their target price on Intuitive Surgical from $294.00 to $255.00 in a research note on Friday, July 22nd. Evercore ISI cut their target price on Intuitive Surgical from $210.00 to $175.00 in a research note on Friday, July 22nd. Morgan Stanley cut their target price on Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating on the stock in a research note on Friday, July 15th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on Intuitive Surgical from $225.00 to $205.00 in a research note on Friday, July 22nd. Six equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $268.00.
Insider Buying and Selling
In related news, EVP Myriam Curet sold 9,000 shares of the stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total transaction of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares in the company, valued at $48,825. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Intuitive Surgical news, EVP Myriam Curet sold 9,000 shares of the firm's stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the transaction, the executive vice president now directly owns 217 shares in the company, valued at $48,825. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 79,412 shares of the firm's stock in a transaction that occurred on Tuesday, July 26th. The shares were sold at an average price of $216.30, for a total value of $17,176,815.60. Following the completion of the transaction, the chief executive officer now owns 54,607 shares of the company's stock, valued at $11,811,494.10. The disclosure for this sale can be found here. Over the last three months, insiders sold 101,162 shares of company stock worth $22,062,916. 0.90% of the stock is owned by corporate insiders.
Intuitive Surgical Company Profile
(Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- Let Paychex Stock Work Hard For You
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
